Skip to main
BIOL
BIOL logo

BIOLASE (BIOL) Market Capitalization Overview

Market Cap: $3.70K as of Oct 7, 2025

$3.70K
Past Month$0.00 (0.00%)
As of Oct 7, 2025, BIOLASE (BIOL) has a market capitalization of $3.70K. Over the past 30 days, its market cap has increased by 0%, while in the last 12 months, it has decreased by -99.16%.

Market capitalization represents the total value of BIOLASE as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

BIOLASE (BIOL) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of BIOLASE (BIOL) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

BIOLASE (BIOL) Market Cap History

DateMarket CapChange
Oct 1, 2025$0.000.00%
Sep 2, 2025$0.00-100.00%
Aug 1, 2025$3.70K-99.05%
Jul 1, 2025$387.90K-11.68%
Jun 2, 2025$439.20K-7.69%
May 1, 2025$475.80K+66.65%
Apr 1, 2025$285.50K-9.28%
Mar 3, 2025$314.70K0.00%
Feb 3, 2025$314.70K+7.48%
Jan 2, 2025$292.80K-2.43%

BIOLASE (BIOL) End of Year Market Cap History

DateMarket CapChange
2025$3.70K-99.16%
2024$439.20K

FAQs About BIOLASE (BIOL) Market Cap

As of Oct 7, 2025, the market capitalization of BIOLASE (BIOL) is $3.70K. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, BIOLASE’s market capitalization has increased by 0.0000%, changing from $3.70K to $3.70K as of Oct 7, 2025.

In the last 3 months, BIOLASE’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, BIOLASE’s market capitalization increased from – in January to $439.20K in December, reflecting a — change.

BIOLASE (BIOL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.